#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13346	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2361	563.1	0	.	n	.	0	A69G	SNP	69	69	A	457	457	G	744	G,A,T	500,198,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13346	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2361	563.1	0	.	n	.	0	C1450T	SNP	1450	1450	C	1838	1838	T	720	T	676	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13346	16S	1529	1529	99.87	16S.l6.c30.ctg.1	2361	563.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1572	1572	C	799	C	743	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23882	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3575	666.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1642	1642	A	799	A,G	744,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23882	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3575	666.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2276	2276	C	738	C,T	688,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23882	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3575	666.1	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2902	2902	T	726	T	685	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	23882	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3575	666.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2350	2350	A	781	A	736	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1840	folP	852	852	99.88	folP.l15.c4.ctg.1	1507	121.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	829	831	AAA	200;200;200	A;A;A	192;193;192	.	.
folP.WHO_K_01359c	folP.WHO_K_01359c	1	1	539	1840	folP	852	852	99.88	folP.l15.c4.ctg.1	1507	121.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1060	1062	AGC	163;162;162	A;G;C	148;147;146	folP.WHO_K_01359c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4542	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3423	132.4	0	.	p	.	0	K261del	DEL	781	781	A	1111	1111	A	146	A	136	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4542	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3423	132.4	1	SNP	p	S91F	0	.	.	271	273	TCC	601	603	TCC	157;156;157	T;C,T;C	152;148,3;151	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4542	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3423	132.4	1	SNP	p	D95G	0	.	.	283	285	GAC	613	615	GAC	153;150;150	G;A,G;C	143;141,3;143	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4542	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3423	132.4	1	SNP	p	D95N	0	.	.	283	285	GAC	613	615	GAC	153;150;150	G;A,G;C	143;141,3;143	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1494	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1297	114.1	1	SNP	p	G45D	0	.	.	133	135	GGC	427	429	GGC	222;220;220	G;G;C	203;203;202	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	724	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1135	63.7	0	.	n	.	0	A197.	DEL	197	197	A	604	604	A	177	A	174	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4414	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2964	148.5	1	SNP	p	D86N	0	.	.	256	258	GAC	585	587	GAC	178;176;177	G,A;A,C;C	165,1;161,1;164	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4414	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2964	148.5	1	SNP	p	S87I	0	.	.	259	261	AGT	588	590	AGT	175;173;176	A,C;G;T	162,1;161;163	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4414	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2964	148.5	1	SNP	p	S87W	0	.	.	259	261	AGT	588	590	AGT	175;173;176	A,C;G;T	162,1;161;163	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4414	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2964	148.5	1	SNP	p	S87R	0	.	.	259	261	AGT	588	590	AGT	175;173;176	A,C;G;T	162,1;161;163	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4414	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2964	148.5	1	SNP	p	S88P	0	.	.	262	264	TCC	591	593	TCC	173;172;177	T;C;C	162;159;163	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3892	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2738	141.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1644	1646	GGC	199;200;199	G;G;C	183;182;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1290	1292	GCA	205;206;208	G;C;A	192;194;196	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1293	1295	ATC	208;208;209	A;T;C	196;196;197	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1305	1307	GTG	203;201;205	G;T;G	192;190;197	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1305	1307	GTG	203;201;205	G;T;G	192;190;197	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1809	1811	ACC	188;187;184	A;C;C	179;178;176	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1863	1865	GCG	170;169;172	G;C;G	151;135;139	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1863	1865	GCG	170;169;172	G;C;G	151;135;139	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1986	1988	GGC	173;170;171	G;G;C	162;160;158	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1995	1997	GGC	165;164;163	G;G;C	154;149;150	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3728	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2426	152.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2013	2015	CTG	148;152;154	C,G;T;G,C	111,6;115;117,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5338	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3141	169.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1666	1668	CCG	171;173;176	C;C;G	162;164;162	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2130	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1809	117.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	140	C	130	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	392	394	GAA	242;243;243	G;A;A	234;237;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	680	682	GAT	195;196;197	G,A;A;T	183,1;181;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	E137G	NONSYN	409	411	GAA	689	691	GGA	206;207;209	G;G,A;A	195;194,1;197	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	803	805	TCA	202;203;204	T;C,A;A	188;189,1;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	932	934	GTC	168;168;169	G;T;C	161;159;163	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	944	946	TCT	173;168;170	T;C;T	165;162;165	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1262	1264	GCA	181;181;184	G;C;A	172;171;172	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	G120K	1	.	.	358	360	AAG	638	640	AAG	213;213;215	A;A;G	201;201;201	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	A121D	1	.	.	361	363	GAC	641	643	GAC	216;213;211	G;A;C	203;202;198	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2590	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1470	175.2	1	SNP	p	D121N	0	.	.	361	363	GAC	641	643	GAC	216;213;211	G;A;C	203;202;198	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9642	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4885	197.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1993	1995	AAT	202;204;205	A;A;T	195;196;194	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1040	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1007	102.5	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	205;202;205	A;T;G,C	192;189;190,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
